PT670892E - Purificacao, composicao e especificidade das heparinases i, ii e iii de flavobacterium heparinum - Google Patents

Purificacao, composicao e especificidade das heparinases i, ii e iii de flavobacterium heparinum

Info

Publication number
PT670892E
PT670892E PT94902450T PT94902450T PT670892E PT 670892 E PT670892 E PT 670892E PT 94902450 T PT94902450 T PT 94902450T PT 94902450 T PT94902450 T PT 94902450T PT 670892 E PT670892 E PT 670892E
Authority
PT
Portugal
Prior art keywords
heparinases
specificity
purification
iii
composition
Prior art date
Application number
PT94902450T
Other languages
English (en)
Inventor
Sasisekharan Ramnath
Daniel L Lohse
Charles L Cooney
Robert J Linhardt
Robert S Langer
Original Assignee
Massachusetts Inst Technology
Univ Iowa Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology, Univ Iowa Res Found filed Critical Massachusetts Inst Technology
Publication of PT670892E publication Critical patent/PT670892E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/85—Flavobacterium

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT94902450T 1992-11-30 1993-11-30 Purificacao, composicao e especificidade das heparinases i, ii e iii de flavobacterium heparinum PT670892E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/983,367 US5389539A (en) 1992-11-30 1992-11-30 Purification of heparinase I, II, and III from Flavobacterium heparinum

Publications (1)

Publication Number Publication Date
PT670892E true PT670892E (pt) 2005-11-30

Family

ID=25529915

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94902450T PT670892E (pt) 1992-11-30 1993-11-30 Purificacao, composicao e especificidade das heparinases i, ii e iii de flavobacterium heparinum

Country Status (10)

Country Link
US (4) US5389539A (pt)
EP (1) EP0670892B1 (pt)
JP (3) JPH08505767A (pt)
AT (1) ATE298366T1 (pt)
CA (1) CA2150263C (pt)
DE (1) DE69333834T2 (pt)
DK (1) DK0670892T3 (pt)
ES (1) ES2243924T3 (pt)
PT (1) PT670892E (pt)
WO (1) WO1994012618A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389539A (en) 1992-11-30 1995-02-14 Massachusetts Institute Of Technology Purification of heparinase I, II, and III from Flavobacterium heparinum
US5681733A (en) * 1994-06-10 1997-10-28 Ibex Technologies Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum
US5997863A (en) * 1994-07-08 1999-12-07 Ibex Technologies R And D, Inc. Attenuation of wound healing processes
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
CA2235223A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
US6458574B1 (en) 1996-09-12 2002-10-01 Transkaryotic Therapies, Inc. Treatment of a α-galactosidase a deficiency
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
JP2003527822A (ja) * 1998-08-27 2003-09-24 マサチューセッツ インスティテュート オブ テクノロジー ヘパリナーゼｉおよびｉｉ由来の合理的に設計されたヘパリナーゼ
WO2000065521A2 (en) * 1999-04-23 2000-11-02 Massachusetts Institute Of Technology System and method for polymer notation
WO2001066772A2 (en) * 2000-03-08 2001-09-13 Massachusetts Institute Of Technology Heparinase iii and uses thereof
CA2422059C (en) 2000-09-12 2012-05-15 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
CA2423469A1 (en) * 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
KR20020046293A (ko) * 2000-12-12 2002-06-21 김영식 글리코사미노글리칸을 분해하는 인간 장내 미생물 유래신규 헤파리네이즈, 그의 제조 방법 및 용도
US20030219854A1 (en) * 2002-03-21 2003-11-27 Micrologix Biotech Inc. Methods for producing modified anti-infective peptides
WO2003102160A2 (en) * 2002-06-03 2003-12-11 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from chondroitinase b
US20040265943A1 (en) * 2002-09-23 2004-12-30 Aventis Pharma S.A. Method for quantitatively determining specific groups constituting heparins or low molecular weight heparins
FR2844808B1 (fr) * 2002-09-23 2005-02-25 Aventis Pharma Sa Methode de determination de groupements specifiques constituant les heparines ou les heparines de bas poids moleculaire
JP4773976B2 (ja) * 2004-01-30 2011-09-14 エモリー ユニバーシティ 神経再生を促進する材料および方法
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
US7767420B2 (en) 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
CN104593347B (zh) * 2015-03-05 2018-08-28 深圳市海普瑞药业集团股份有限公司 来自Sphingobacterium daejeonense的肝素酶及其制备和应用
CN114787195B (zh) * 2019-12-27 2024-01-12 深圳市天道医药有限公司 一种肝素酶iii的制备方法
CN113046358A (zh) * 2021-03-10 2021-06-29 华侨大学 一种重组鱼精蛋白专用编码基因和制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54107584A (en) * 1978-02-10 1979-08-23 Seikagaku Kogyo Co Ltd Preparation of pure heparinase
IL61201A (en) 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
IT1141249B (it) 1980-02-28 1986-10-01 Italfarmaco Spa Procedimento per la preparazione di copolimeri di polisaccaridi supprotanti attivita' enzimatica,e copolimeri cosi' ottenuti
US4443545A (en) * 1980-08-25 1984-04-17 Massachusetts Institute Of Technology Process for producing heparinase
US4341869A (en) * 1980-08-25 1982-07-27 Massachusetts Institute Of Technology Process for producing heparinase
US4373023A (en) * 1980-10-14 1983-02-08 Massachusetts Institute Of Technology Process for neutralizing heparin
US4396762A (en) * 1981-08-24 1983-08-02 Massachusetts Institute Of Technology Heparinase derived anticoagulants
US4847338A (en) 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
FR2584728B1 (fr) 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US4795703A (en) 1986-03-07 1989-01-03 The Children's Medical Center Corporation Heparin assay
US4885207A (en) 1987-07-13 1989-12-05 Uop Biocompatible protein or ligand immobilization system
ATE113991T1 (de) * 1988-06-06 1994-11-15 Massachusetts Inst Technology Verfahren zur reinigung hochreiner heparinase in grosser menge.
US5169772A (en) * 1988-06-06 1992-12-08 Massachusetts Institute Of Technology Large scale method for purification of high purity heparinase from flavobacterium heparinum
JP2726275B2 (ja) * 1988-08-24 1998-03-11 生化学工業株式会社 グリコサミノグリカン分解酵素の精製法
JP2833793B2 (ja) 1989-09-19 1998-12-09 科学技術振興事業団 ヘパリナーゼをコードするプラスミド、このプラスミドを保持するヘパリナーゼ生産株及びヘパリナーゼの製造法
JP3108486B2 (ja) 1991-11-19 2000-11-13 古河電気工業株式会社 セラミックス超電導導体
US5389539A (en) 1992-11-30 1995-02-14 Massachusetts Institute Of Technology Purification of heparinase I, II, and III from Flavobacterium heparinum

Also Published As

Publication number Publication date
DE69333834T2 (de) 2006-06-01
JP2004135684A (ja) 2004-05-13
DK0670892T3 (da) 2005-08-15
USRE41328E1 (en) 2010-05-11
ES2243924T3 (es) 2005-12-01
JPH08505767A (ja) 1996-06-25
US5569600A (en) 1996-10-29
WO1994012618A1 (en) 1994-06-09
EP0670892B1 (en) 2005-06-22
US5389539A (en) 1995-02-14
JP2005278651A (ja) 2005-10-13
USRE41461E1 (en) 2010-07-27
EP0670892A4 (en) 1997-05-28
ATE298366T1 (de) 2005-07-15
EP0670892A1 (en) 1995-09-13
DE69333834D1 (de) 2005-07-28
CA2150263A1 (en) 1994-06-09
CA2150263C (en) 1998-08-04

Similar Documents

Publication Publication Date Title
PT670892E (pt) Purificacao, composicao e especificidade das heparinases i, ii e iii de flavobacterium heparinum
Ouyang et al. Fibrinogenolytic enzymes of Trimeresurus mucrosquamatus venom
ATE167230T1 (de) Wundheilmittel enthaltend heparanase
DK399588A (da) Pentasaccharider
NO992353L (no) Rensing av neurotrofiner
WO1993000330A3 (en) Azanorbornane derivatives
ATE328067T1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
ES8700672A1 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
DE69531990D1 (de) Bicyclischer lactaminhibitor des interleukin-1-beta-konvertierenden enzyms
ES2117123T3 (es) Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina.
BR8600944A (pt) Instalacao para a purificacao anaerobica de agua de rejeito
ATE274346T1 (de) Tnf-alpha konvertierendes enzym
FI854843A (fi) Foerfarande foer producering av ligninolytiskt ensym med hjaelp av kultur av mikro-organismer av stammen phanerochaete chrysosporium.
MX9305093A (es) Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa.
ES8707565A1 (es) Un procedimiento para producir un anticuerpo monoclonal
EA199900511A1 (ru) N-связанные мочевины и карбаматы сложных гетероциклических тиоэфиров
ATE267209T1 (de) Reinigung von carboxaldehyd
DE69534491T2 (de) Cephalosporin-c-amidohydrolase herstellung und verwendung
ATE56617T1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
ES2001564A6 (es) Procedimiento para la obtencion de tiazolilalquil y tienilalquilesteres de los acidos alfa-imidazolinon nicotinicos y benzoicos
TR199700216A2 (xx) Akarviosil transferaz haz�rlanmas� ve bunun, akarboz homologlar� haz�rlamak �zere, akarboz homologlar�n�n akarboza d�n��t�r�lmesinde kullan�lmas� i�in y�ntemler.
SE7603040L (sv) Forfarande for rening av heparin
ES8801383A1 (es) Un procedimiento para purificar uromodulina a partir de orina cruda
Nelson et al. Anilinonaphthalene sulfonate isomers inactivate phosphoenolpyruvate carboxykinase
ATE209910T1 (de) Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen